​

BioXcel Therapeutics (BTAI) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChart

BioXcel Therapeutics Revenue Highlights

Latest Revenue (Y)

$642.00K

Latest Revenue (Q)

$206.00K

BioXcel Therapeutics Revenue by Period

BioXcel Therapeutics Revenue by Year

DateRevenueChange
2025-12-31$642.00K-71.67%
2024-12-31$2.27M64.20%
2023-12-31$1.38M268.00%
2022-12-31$375.00K100.00%
2021-12-31-100.00%
2020-12-31-100.00%
2019-12-31-100.00%
2018-12-31-100.00%
2017-12-31-100.00%
2016-12-31-100.00%
2015-12-31--

BioXcel Therapeutics generated $642.00K in revenue during NA 2025, up -71.67% compared to the previous quarter, and up Infinity% compared to the same period a year ago.

BioXcel Therapeutics Revenue by Quarter

DateRevenueChange
2026-03-31$206.00K-19.53%
2025-12-31$256.00K161.22%
2025-09-30$98.00K-18.33%
2025-06-30$120.00K-28.57%
2025-03-31$168.00K-54.10%
2024-12-31$366.00K71.03%
2024-09-30$214.00K-80.62%
2024-06-30$1.10M89.69%
2024-03-31$582.00K54.79%
2023-12-31$376.00K10.26%
2023-09-30$341.00K-25.38%
2023-06-30$457.00K121.84%
2023-03-31$206.00K-13.45%
2022-12-31$238.00K73.72%
2022-09-30$137.00K100.00%
2022-06-30-100.00%
2022-03-31-100.00%
2021-12-31-100.00%
2021-09-30-100.00%
2021-06-30-100.00%
2021-03-31-100.00%
2020-12-31-100.00%
2020-09-30-100.00%
2020-06-30-100.00%
2020-03-31-100.00%
2019-12-31-100.00%
2019-09-30-100.00%
2019-06-30-100.00%
2019-03-31-100.00%
2018-12-31-100.00%
2018-09-30-100.00%
2018-06-30-100.00%
2018-03-31-100.00%
2017-12-31-100.00%
2017-09-30-100.00%
2017-06-30-100.00%
2017-03-31--

BioXcel Therapeutics generated $206.00K in revenue during Q1 2026, up -19.53% compared to the previous quarter, and up 56.28% compared to the same period a year ago.

BioXcel Therapeutics Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
CELUCelularity$26.55M$5.28M
GBIOGeneration Bio$19.89M$765.00K
BTAIBioXcel Therapeutics$642.00K$206.00K
EVAXEvaxion Biotech$73.11K$50.88K
VERUVeru-$56.39K
RVPHReviva Pharmaceuticals--
BCABBioAtla--
MURAMural Oncology--
PYPDPolyPid--
ANVSAnnovis Bio--

BTAI Revenue FAQ

What is BioXcel Therapeutics’s yearly revenue?

BioXcel Therapeutics's yearly revenue for 2025 was $642K, representing a decrease of -71.67% compared to 2024. The company's yearly revenue for 2024 was $2.27M, representing an increase of 64.20% compared to 2023. BTAI's yearly revenue for 2023 was $1.38M, representing an increase of 268.00% compared to 2022.

What is BioXcel Therapeutics’s quarterly revenue?

BioXcel Therapeutics's quarterly revenue for Q1 2026 was $206K, a -19.53% decrease from the previous quarter (Q4 2025), and a 22.62% increase year-over-year (Q1 2025). The company's quarterly revenue for Q4 2025 was $256K, a 161.22% increase from the previous quarter (Q3 2025), and a -30.05% decrease year-over-year (Q4 2024). BTAI's quarterly revenue for Q3 2025 was $98K, a -18.33% decrease from the previous quarter (Q2 2025), and a -54.21% decrease year-over-year (Q3 2024).

What is BioXcel Therapeutics’s revenue growth rate?

BioXcel Therapeutics's revenue growth rate for the last 3 years (2023-2025) was -53.48%, and for the last 5 years (2021-2025) was 0%.